PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F09PB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $19,346
Award facts
- Contract value 100% obligated
- $19,346.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on December 13, 2025, represents a $19,346.18 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and carries an ultimate completion date of December 15, 2025, with no set-aside designation applied. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The DLA Medical Supply Chain leverages AmerisourceBergen's extensive pharmaceutical and medical supply portfolio to support Defense Health Agency operations and other federal healthcare systems worldwide. The prime indefinite delivery vehicle enables the contractor to supply critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's selection through competitive procurement reflects the company's established capability to meet federal medical procurement requirements. The Defense Logistics Agency is currently planning the next generation of Pharmaceutical Prime Vendor Global Program contracts (Generation V), which will involve multiple awards distributed across separate regions, positioning various qualified contractors to support evolving military healthcare supply needs.
Quick answers
Who was awarded contract SPE2D826F09PB?
SPE2D826F09PB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 13, 2025.
How much is contract SPE2D826F09PB worth?
The government has obligated $19,346 on SPE2D826F09PB.
Is contract SPE2D826F09PB an order under another contract?
Yes. SPE2D826F09PB is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F09PB competed?
The extent of competition for SPE2D826F09PB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award